Canada Life
ANIP icon

Canada Life’s ANI Pharmaceuticals ANIP Stock Holding History

Canada Life’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.08M Sell
14,074
-998
-7% -$77.9K ﹤0.01% 1343
2025
Q4 		$1.19M Sell
15,072
-4,970
-25% -$430K ﹤0.01% 1342
2025
Q3 		$1.84M Buy
20,042
+634
+3% +$51.7K ﹤0.01% 1259
2025
Q2 		$1.27M Buy
19,408
+198
+1% +$12.9K ﹤0.01% 1358
2025
Q1 		$1.29M Sell
19,210
-2,479
-11% -$148K ﹤0.01% 1353
2024
Q4 		$1.2M Hold
21,689
– – ﹤0.01% 1425
2024
Q3 		$1.29M Buy
21,689
+1,332
+7% +$81.3K ﹤0.01% 1449
2024
Q2 		$1.29M Buy
20,357
+7,321
+56% +$475K ﹤0.01% 1442
2024
Q1 		$900K Buy
13,036
+909
+7% +$54.9K ﹤0.01% 1525
2023
Q4 		$668K Sell
12,127
-1,591
-12% -$87.6K ﹤0.01% 1624
2023
Q3 		$796K Buy
13,718
+2,111
+18% +$122K ﹤0.01% 1561
2023
Q2 		$625K Buy
11,607
+591
+5% +$26.2K ﹤0.01% 1629
2023
Q1 		$437K Sell
11,016
-1,646
-13% -$69.4K ﹤0.01% 1729
2022
Q4 		$507K Buy
12,662
+510
+4% +$19.2K ﹤0.01% 1717
2022
Q3 		$390K Hold
12,152
– – ﹤0.01% 1735
2022
Q2 		$360K Buy
12,152
+1,346
+12% +$38.8K ﹤0.01% 1734
2022
Q1 		$311K Buy
10,806
+1,578
+17% +$58.8K ﹤0.01% 1808
2021
Q4 		$423K Buy
9,228
+1,017
+12% +$43.7K ﹤0.01% 1737
2021
Q3 		$272K Hold
8,211
– – ﹤0.01% 1846
2021
Q2 		$287K Hold
8,211
– – ﹤0.01% 1855
2021
Q1 		$295K Sell
8,211
-1,275
-13% -$39.9K ﹤0.01% 1855
2020
Q4 		$275K Sell
9,486
-1,246
-12% -$35.7K ﹤0.01% 1898
2020
Q3 		$303K Hold
10,732
– – ﹤0.01% 1800
2020
Q2 		$347K Sell
10,732
-1,443
-12% -$51.7K ﹤0.01% 1775
2020
Q1 		$493K Buy
12,175
+953
+8% +$50.7K ﹤0.01% 1595
2019
Q4 		$687K Buy
11,222
+547
+5% +$36.2K ﹤0.01% 1630
2019
Q3 		$778K Sell
10,675
-751
-7% -$56.2K ﹤0.01% 900
2019
Q2 		$939K Sell
11,426
-556
-5% -$39.5K ﹤0.01% 1574
2019
Q1 		$844K Hold
11,982
– – ﹤0.01% 1457
2018
Q4 		$500K Buy
11,982
+1,413
+13% +$74.1K ﹤0.01% 1672
2018
Q3 		$596K Sell
10,569
-2,045
-16% -$125K ﹤0.01% 1697
2018
Q2 		$842K Hold
12,614
– – ﹤0.01% 1592
2018
Q1 		$734K Hold
12,614
– – ﹤0.01% 1617
2017
Q4 		$812K Hold
12,614
– – ﹤0.01% 1591
2017
Q3 		$650K Hold
12,614
– – ﹤0.01% 1652
2017
Q2 		$590K Buy
12,614
+1,000
+9% +$48.2K ﹤0.01% 1671
2017
Q1 		$574K Hold
11,614
– – ﹤0.01% 1676
2016
Q4 		$704K Hold
11,614
– – ﹤0.01% 1604
2016
Q3 		$771K Buy
11,614
+1,160
+11% +$72.6K ﹤0.01% 1538
2016
Q2 		$584K Buy
+10,454
New +$508K ﹤0.01% 1608
2015
Q3 		– Sell
-83
Closed -$5K – 2444
2015
Q2 		$5K Hold
83
– – ﹤0.01% 2576
2015
Q1 		$5K Hold
83
– – ﹤0.01% 2482
2014
Q4 		$4K Hold
83
– – ﹤0.01% 2486
2014
Q3 		$2K Hold
83
– – ﹤0.01% 2481
2014
Q2 		$3K Hold
83
– – ﹤0.01% 2369
2014
Q1 		$3K Hold
83
– – ﹤0.01% 2259
2013
Q4 		$1K Hold
83
– – ﹤0.01% 2258
2013
Q3 		$1K Buy
+83
New +$598 ﹤0.01% 1157

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Canada Life's ANIP Position: Q1 2026 in Review

Canada Life reduced its ANI Pharmaceuticals (ANIP) stake by 6.6% in Q1 2026, selling an estimated $77.9K and leaving 14,074 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #1343.

Canada Life first reported a position in ANIP in Q3 2013 and has held it in 48 quarters since. The position peaked at $1.84M in Q3 2025. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

  • Canada Life held 14,074 shares of ANI Pharmaceuticals worth $1.08M as of Q1 2026.
  • Canada Life sold 998 ANI Pharmaceuticals shares in Q1 2026, an estimated $77.9K.
  • ANI Pharmaceuticals made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1343 holding.
  • Canada Life first reported a position in ANI Pharmaceuticals in Q3 2013 and has held it in 48 quarters since.
  • Canada Life's ANI Pharmaceuticals position peaked at $1.84M in Q3 2025.
  • 280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.